G. Paolisso et al., DOES FREE FATTY-ACID INFUSION IMPAIR INSULIN ACTION ALSO THROUGH AN INCREASE IN OXIDATIVE STRESS, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4244-4248
In vitro studies have demonstrated that free fatty acids (FFA) may enh
ance oxidative stress. In contrast, no in vivo studies have addressed
such a relationship. This four-part study aims at investigating the as
sociation between FFA and oxidative stress in healthy volunteers. The
following experimental procedures were carried out: 1) determination a
nd simple correlations among fasting plasma FFA, glucose, insulin, pla
sma thiobarbituric acid-reactive substance (TBARS), the ratio of reduc
ed glutathione (GSH) to oxidized GSH, and lipid hydroperoxide (n=30);
2) time-dependent effect of FFA on plasma TBARS concentrations and GSH
/oxidized GSH ratio (n=10); 3) dose-dependent effect of FFA on plasma
TBARS concentrations (n=9); and 4) relationship among plasma FFA conce
ntrations, plasma TBARS concentrations, and insulin action (n=11). The
results demonstrate that fasting plasma FFA concentrations correlated
with fasting plasma TBARS concentrations (r=0.65; P <0.001) and lipid
hydroperoxide (r=0.79; P <0.001). The correlation between plasma FFA
and TBARS remained significant even after adjustment for age, sex, bod
y mass index, and fasting and 2-h plasma glucose concentrations (r=0.4
3; P <0.01). In the time-dependent study, plasma TBARS concentrations
increased with the rise in plasma FFA concentrations. In the dose-resp
onse study, a progressive increase in fasting plasma FFA concentration
s was achieved by varying the Intralipid infusion rate, which also cau
sed plasma TBARS concentrations to increase progressively until they r
eached a plateau between the last two infusion rates (0.3 and 0.4 mL/m
in). A euglycemic hyperinsulinemic glucose clamp (insulin infusion rat
e, 10.2 pmol/kg . min for 360 min) was also performed. Simultaneous 10
% Intralipid (0.4 mL/min) infusion significantly enhanced plasma TBARS
concentrations and inhibited insulin-stimulated whole body glucose di
sposal (WBGD). GSH infusion (15 mg/min for 360 min) had opposite effec
ts on plasma TBARS concentrations and WBGD. A combined infusion of 10%
Intralipid and GSH was associated with a stimulation of WBGD with a m
agnitude midway between that of 10% Intralipid and GSH infused separat
ely. In conclusion, fasting plasma FFA seems to enhances oxidative str
ess, which might contribute to the disruptive effects of plasma FFA on
insulin-mediated glucose uptake.